U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06855368) titled 'Biomarkers for Monitoring Dementia Progression' on Jan. 29.
Brief Summary: The variable course of Alzheimer's disease (AD) and the paucity of adequate cures urges to implement new strategies for its early detection and clinical intervention. Studying the etiopathogenesis and pathophysiological mechanisms of AD is a necessary prerequisite for the development of new biomarkers and innovative therapies. Contrarily to anatomical structures, cortical connectivity networks are already deteriorated in early AD and could be a reliable marker of early cognitive decline. Our aim is to characterize the neurophysiological parameters in mild AD,...